Aging Biology in the Kidney

Advances in Chronic Kidney Disease

Volumn 23, Issue 1, 2016, Pages 12-18

  Bitzer, Markus ^a,b   Wiggins, Jocelyn ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Division of Geriatric Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KLOTHO PROTEIN; MICRORNA 21; REACTIVE OXYGEN METABOLITE; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7;

AGING; CALORIC RESTRICTION; CELL AGING; DNA DAMAGE; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; LIFE EXTENSION; LONGEVITY; NONHUMAN; OXIDATIVE STRESS; POINT MUTATION; PRIORITY JOURNAL; PROGERIA; PROTEIN EXPRESSION; REVIEW; RNA PROCESSING; SIGNAL TRANSDUCTION; TELOMERE SHORTENING; AGED; GENETIC EPIGENESIS; GENETICS; KIDNEY; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL INSUFFICIENCY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; DNA DAMAGE; EPIGENESIS, GENETIC; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; RENAL INSUFFICIENCY; SIGNAL TRANSDUCTION;

EID: 84953318751     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2015.11.005     Document Type: Review

References (78)

1. Glassock R.J., Oreopoulos D.G. Aging and chronic kidney disease. Nephron Clin Pract 2011, 119(Suppl 1):c1.
2. Winearls C.G., Glassock R.J. Classification of chronic kidney disease in the elderly: pitfalls and errors. Nephron Clin Pract 2011, 119(Suppl 1):c2-c4.
3. Kenyon C., Chang J., Gensch E., Rudner A., Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature 1993, 366(6454):461-464.
4. Kimura K.D., Tissenbaum H.A., Liu Y., Ruvkun G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 1997, 277(5328):942-946.
5. Kenyon C.J. The genetics of ageing. Nature 2010, 464(7288):504-512.
6. Yuan R., Tsaih S.W., Petkova S.B., et al. Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels. Aging Cell 2009, 8(3):277-287.
7. Pawlikowska L., Hu D., Huntsman S., et al. Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell 2009, 8(4):460-472.
8. Kapahi P., Zid B. TOR pathway: linking nutrient sensing to life span. Sci Aging Knowledge Environ 2004, 2004(36):PE34.
9. Kapahi P., Chen D., Rogers A.N., et al. With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab 2010, 11(6):453-465.
10. Johnson S.C., Rabinovitch P.S., Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature 2013, 493(7432):338-345.
11. Harrison D.E., Strong R., Sharp Z.D., et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460(7253):392-395.
12. Neff F., Flores-Dominguez D., Ryan D.P., et al. Rapamycin extends murine lifespan but has limited effects on aging. J Clin Invest 2013, 123(8):3272-3291.
13. Leontieva O.V., Paszkiewicz G.M., Blagosklonny M.V. Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet. Aging Cell 2014, 13(4):616-622.
14. Sinclair D.A., Guarente L. Extrachromosomal rDNA circles-a cause of aging in yeast. Cell 1997, 91(7):1033-1042.
15. Kaeberlein M., McVey M., Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 1999, 13(19):2570-2580.
16. Verdin E., Hirschey M.D., Finley L.W., Haigis M.C. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci 2010, 35(12):669-675.
17. Mostoslavsky R., Chua K.F., Lombard D.B., et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006, 124(2):315-329.
18. Giblin W., Skinner M.E., Lombard D.B. Sirtuins: guardians of mammalian healthspan. Trends Genet 2014, 30(7):271-286.
19. Mercken E.M., Mitchell S.J., Martin-Montalvo A., et al. SRT2104 extends survival of male mice on a standard diet and preserves bone and muscle mass. Aging Cell 2014, 13(5):787-796.
20. Mitchell S.J., Martin-Montalvo A., Mercken E.M., et al. The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet. Cell Rep 2014, 6(5):836-843.
21. Kuro-o M., Matsumura Y., Aizawa H., et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997, 390(6655):45-51.
22. Kurosu H., Yamamoto M., Clark J.D., et al. Suppression of aging in mice by the hormone Klotho. Science 2005, 309(5742):1829-1833.
23. Wang Y., Sun Z. Current understanding of klotho. Ageing Res Rev 2009, 8(1):43-51.
24. Kuro-o M. Klotho and aging. Biochim Biophys Acta 2009, 1790(10):1049-1058.
25. Hu M.C., Kuro-o M., Moe O.W. Klotho and chronic kidney disease. Contrib Nephrol 2013, 180:47-63.
26. Arking D.E., Krebsova A., Macek M., et al. Association of human aging with a functional variant of klotho. Proc Natl Acad Sci U S A 2002, 99(2):856-861.
27. Hoeijmakers J.H. DNA damage, aging, and cancer. N Engl J Med 2009, 361(15):1475-1485.
28. Delahunt B., Stehbens W.E., Gilbert-Barness E., Shozawa T., Ruger B.M. Progeria kidney has abnormal mesangial collagen distribution. Pediatr Nephrol 2000, 15(3-4):279-285.
29. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120(4):513-522.
30. Westhoff J.H., Schildhorn c., Jacobi C., et al. Telomere shortening reduces regenerative capacity after acute kidney injury. J Am Soc Nephrol 2010, 21(2):327-336.
31. Feest T.G., Round A., Hamad S. Incidence of severe acute renal failure in adults: results of a community based study. BMJ 1993, 306(6876):481-483.
32. Wardle E.N. Acute renal failure and multiorgan failure. Nephrol Dial Transplant 1994, 9(Suppl 4):104-107.
33. Schmitt R., Coca S., Kanbay M., Tinetti M.E., Cantley L.G., Parikh C.R. Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis. Am J Kidney Dis 2008, 52(2):262-271.
34. Wiggins J.E., Patel S.R., Shedden K.A., et al. NFkappaB promotes inflammation, coagulation, and fibrosis in the aging glomerulus. J Am Soc Nephrol 2010, 21(4):587-597.
35. Smith-Vikos T., Slack F.J. MicroRNAs and their roles in aging. J Cell Sci 2012, 125(Pt 1):7-17.
36. Leung A.K., Sharp P.A. MicroRNA functions in stress responses. Mol Cell 2010, 40(2):205-215.
37. Olivieri F., Rippo M.R., Monsurro V., et al. MicroRNAs linking inflamm-aging, cellular senescence and cancer. Ageing Res Rev 2013, 12(4):1056-1068.
38. Grillari J., Grillari-Voglauer R. Novel modulators of senescence, aging, and longevity: Small non-coding RNAs enter the stage. Exp Gerontol 2010, 45(4):302-311.
39. Kato M., Arce L., Natarajan R. MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol 2009, 4(7):1255-1266.
40. Ho J., Kreidberg J.A. MicroRNAs in renal development. Pediatr Nephrol 2013, 28(2):219-225.
41. Ho J.J., Marsden P.A. Dicer cuts the kidney. J Am Soc Nephrol 2008, 19(11):2043-2046.
42. Sataranatarajan K., Feliers D., Mariappan M.M., et al. Molecular events in matrix protein metabolism in the aging kidney. Aging Cell 2012, 11(6):1065-1073.
43. Bai X.Y., Ma Y., Ding R., Fu B., Shi S., Chen X.M. miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes. J Am Soc Nephrol 2011, 22(7):1252-1261.
44. Olivieri F., Spazzafumo L., Santini G., et al. Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging. Mech Ageing Dev 2012, 133(11-12):675-685.
45. Lai J.Y., Luo J., O'Connor C., et al. MicroRNA-21 in glomerular injury. J Am Soc Nephrol 2015, 26(4):805-816.
46. Chau B.N., Xin C., Hartner J., et al. MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways. Sci Transl Med 2012, 4(121):121ra118.
47. Godwin J.G., Ge X., Stephan K., Jurisch A., Tullius S.G., Iacomini J. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci U S A 2010, 107(32):14339-14344.
48. Hodgin J.B., Bitzer M., Wickman L., et al. Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective. J Am Soc Nephrol 2015, 26(12):3162-3178.
49. Geanacopoulos M. The determinants of lifespan in the nematode Caenorhabditis elegans: a short primer. Sci Prog 2004, 87(Pt 4):227-247.
50. Edgar D., Trifunovic A. The mtDNA mutator mouse: Dissecting mitochondrial involvement in aging. Aging (Albany NY) 2009, 1(12):1028-1032.
51. Cuervo A.M., Bergamini E., Brunk U.T., Droge W., Ffrench M., Terman A. Autophagy and aging: the importance of maintaining "clean" cells. Autophagy 2005, 1(3):131-140.
52. Hartleben B., Godel M., Meyer-Schwesinger C., et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 2010, 120(4):1084-1096.
53. Muller F.L., Lustgarten M.S., Jang Y., Richardson A., Van Remmen H. Trends in oxidative aging theories. Free Radic Biol Med 2007, 43(4):477-503.
54. Ferrucci L. The Baltimore Longitudinal Study of Aging (BLSA): a 50-year-long journey and plans for the future. J Gerontol A Biol Sci Med Sci 2008, 63(12):1416-1419.
55. Vlassara H., Torreggiani M., Post J.B., Zheng F., Uribarri J., Striker G.E. Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging. Kidney Int Suppl 2009, 76(114):S3-S11.
56. Vlassara H., Uribarri J., Ferrucci L., et al. Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons. Semin Nephrol 2009, 29(6):594-603.
57. Makita Z., Yanagisawa K., Kuwajima S., et al. Advanced glycation endproducts and diabetic nephropathy. J Diabetes Complications 1995, 9(4):265-268.
58. Muntner P., Coresh J., Smith J.C., Eckfeldt J., Klag M.J. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 2000, 58(1):293-301.
59. Okamura D.M., Pennathur S., Pasichnyk K., et al. CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD. J Am Soc Nephrol 2009, 20(3):495-505.
60. Wiggins J.E., Goyal M., Wharram B.L., Wiggins R.C. Antioxidant ceruloplasmin is expressed by glomerular parietal epithelial cells and secreted into urine in association with glomerular aging and high-calorie diet. J Am Soc Nephrol 2006, 17(5):1382-1387.
61. Thornalley P.J. Advanced glycation end products in renal failure. J Ren Nutr 2006, 16(3):178-184.
62. Thomas M.C. Advanced glycation end products. Contrib Nephrol 2011, 170:66-74.
63. Bolton W.K., Cattran D.C., Williams M.E., et al. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am J Nephrol 2004, 24(1):32-40.
64. Mallipattu S.K., Uribarri J. Advanced glycation end product accumulation: a new enemy to target in chronic kidney disease?. Curr Opin Nephrol Hypertens 2014, 23(6):547-554.
65. Aldini G., Vistoli G., Stefek M., et al. Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products. Free Radic Res 2013, 47(Suppl 1):93-137.
66. Bakris G.L., Bank A.J., Kass D.A., Neutel J.M., Preston R.A., Oparil S. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process. Am J Hypertens 2004, 17(12 Pt 2):23S-30S.
67. Tan A.L., Forbes J.M., Cooper M.E. AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol 2007, 27(2):130-143.
68. McCay C.M., Crowell M.F., Maynard L.A. The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. Nutrition 1989, 5(3):155-171. discussion 172.
69. Maeda H., Gleiser C.A., Masoro E.J., Murata I., McMahan C.A., Yu B.P. Nutritional influences on aging of Fischer 344 rats: II. Pathology. J Gerontol 1985, 40(6):671-688.
70. Yu B.P., Masoro E.J., McMahan C.A. Nutritional influences on aging of Fischer 344 rats: I. Physical, metabolic, and longevity characteristics. J Gerontol 1985, 40(6):657-670.
71. Masoro E.J. Dietary restriction and aging. J Am Geriatr Soc 1993, 41(9):994-999.
72. Liao C.Y., Rikke B.A., Johnson T.E., Diaz V., Nelson J.F. Genetic variation in the murine lifespan response to dietary restriction: from life extension to life shortening. Aging Cell 2010, 9(1):92-95.
73. Nadon N.L. Of mice and monkeys: National Institute on Aging resources supporting the use of animal models in biogerontology research. J Gerontol A Biol Sci Med Sci 2006, 61(8):813-815.
74. Kemnitz J.W. Calorie restriction and aging in nonhuman primates. ILAR J 2011, 52(1):66-77.
75. Colman R.J., Beasley T.M., Kemnitz J.W., Johnson S.C., Weindruch R., Anderson R.M. Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys. Nature Commun 2014, 1(5):3557.
76. Mattison J.A., Roth G.S., Beasley T.M., et al. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 2012, 489(7415):318-321.
77. Wiggins J.E., Goyal M., Sanden S.K., et al. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol 2005, 16(10):2953-2966.
78. Redman L.M., Ravussin E. Caloric restriction in humans: impact on physiological, psychological, and behavioral outcomes. Antioxid Redox Signal 2011, 14(2):275-287.